Similar to the shuPAR effect, the combination of resveratrol and cetuximab led to almost complete suppression of tumor growth in mice resistant to cetuximab (SAS-R, Sa3-R) with significant down-regulation of the uPAR/integrin β1 signaling pathway (Figs 5A,B and 6B). This evidence concerns the gene PLAUR and neoplasm.